Thomas Flaten

Stock Analyst at Lake Street

(3.21)
# 1,094
Out of 5,150 analysts
36
Total ratings
42.11%
Success rate
5.84%
Average return

Stocks Rated by Thomas Flaten

Insight Molecular Diagnostics
Feb 17, 2026
Maintains: Buy
Price Target: $8$12
Current: $5.47
Upside: +119.38%
Castle Biosciences
Jan 12, 2026
Maintains: Buy
Price Target: $35$52
Current: $28.17
Upside: +84.59%
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $23.01
Upside: +117.30%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.59
Upside: +247.49%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7$9
Current: $3.42
Upside: +163.16%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6$11
Current: $3.11
Upside: +253.70%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42$70
Current: $39.22
Upside: +78.48%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9$13
Current: $8.04
Upside: +61.69%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $4.36
Upside: +83.49%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11$14
Current: $7.77
Upside: +80.18%
Initiates: Buy
Price Target: $8
Current: $2.61
Upside: +207.10%
Maintains: Buy
Price Target: $60$40
Current: $15.30
Upside: +161.44%
Maintains: Buy
Price Target: $10$8
Current: $4.37
Upside: +83.07%
Maintains: Buy
Price Target: $7$9
Current: $8.93
Upside: +0.78%
Maintains: Buy
Price Target: $60$45
Current: $12.07
Upside: +272.83%
Maintains: Buy
Price Target: $19$11
Current: $4.58
Upside: +140.17%
Maintains: Buy
Price Target: $34$25
Current: $20.67
Upside: +20.95%
Maintains: Buy
Price Target: $14,400$1,440
Current: $0.50
Upside: +285,104.99%